Literature DB >> 23109977

Interobserver variability in diagnosing high-grade neuroendocrine carcinoma of the lung and comparing it with the morphometric analysis.

Seung Yeon Ha1, Joungho Han, Wan-Seop Kim, Byung Seong Suh, Mee Sook Roh.   

Abstract

BACKGROUND: Distinguishing small cell lung carcinoma (SCLC) and large cell neuroendocrine carcinoma (LCNEC) of the lung is difficult with little information about interobserver variability.
METHODS: One hundred twenty-nine cases of resected SCLC and LCNEC were independently evaluated by four pathologists and classified according to the 2004 World Health Organization criteria. Agreement was regarded as "unanimous" if all four pathologists agreed on the classification. The kappa statistic was calculated to measure the degree of agreement between pathologists. We also measured cell size using image analysis, and receiver-operating-characteristic curve analysis was performed to evaluate cell size in predicting the diagnosis of high-grade neuroendocrine (NE) carcinomas in 66 cases.
RESULTS: Unanimous agreement was achieved in 55.0% of 129 cases. The kappa values ranged from 0.35 to 0.81. Morphometric analysis reaffirmed that there was a continuous spectrum of cell size from SCLC to LCNEC and showed that tumors with cells falling in the middle size range were difficult to categorize and lacked unanimous agreement.
CONCLUSIONS: Our results provide an objective explanation for considerable interobserver variability in the diagnosis of high-grade pulmonary NE carcinomas. Further studies would need to define more stringent and objective definitions of cytologic and architectural characteristics to reliably distinguish between SCLC and LCNEC.

Entities:  

Keywords:  Image analysis; Large cell neuroendocrine carcinoma; Lung; Observer variation; Small cell lung carcinoma

Year:  2012        PMID: 23109977      PMCID: PMC3479709          DOI: 10.4132/KoreanJPathol.2012.46.1.42

Source DB:  PubMed          Journal:  Korean J Pathol        ISSN: 1738-1843


  7 in total

1.  Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability.

Authors:  Michael A den Bakker; Sten Willemsen; Katrien Grünberg; L Arnold Noorduijn; Matthijs F M van Oosterhout; Robert J van Suylen; Wim Timens; Bart Vrugt; Anne Wiersma-van Tilburg; Frederik B J M Thunnissen
Journal:  Histopathology       Date:  2010-02       Impact factor: 5.087

2.  Should large cell neuroendocrine lung carcinoma be classified and treated as a small cell lung cancer or with other large cell carcinomas?

Authors:  John M Varlotto; Laura Nyshel Medford-Davis; Abram Recht; John C Flickinger; Eric Schaefer; Dani S Zander; Malcolm M DeCamp
Journal:  J Thorac Oncol       Date:  2011-06       Impact factor: 15.609

3.  Reproducibility of neuroendocrine lung tumor classification.

Authors:  W D Travis; A A Gal; T V Colby; D S Klimstra; R Falk; M N Koss
Journal:  Hum Pathol       Date:  1998-03       Impact factor: 3.466

4.  Neuroendocrine neoplasms of the lung: a prognostic spectrum.

Authors:  Hisao Asamura; Toru Kameya; Yoshihiro Matsuno; Masayuki Noguchi; Hirohito Tada; Yuichi Ishikawa; Tomoyuki Yokose; Shi-Xu Jiang; Takeshi Inoue; Ken Nakagawa; Kinuko Tajima; Kanji Nagai
Journal:  J Clin Oncol       Date:  2006-01-01       Impact factor: 44.544

5.  Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases.

Authors:  W D Travis; R I Linnoila; M G Tsokos; C L Hitchcock; G B Cutler; L Nieman; G Chrousos; H Pass; J Doppman
Journal:  Am J Surg Pathol       Date:  1991-06       Impact factor: 6.394

Review 6.  Advances in neuroendocrine lung tumors.

Authors:  W D Travis
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

7.  Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms.

Authors:  A M Marchevsky; A A Gal; S Shah; M N Koss
Journal:  Am J Clin Pathol       Date:  2001-10       Impact factor: 2.493

  7 in total
  8 in total

1.  Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.

Authors:  Alessandra Fabbri; Mara Cossa; Angelica Sonzogni; Mauro Papotti; Luisella Righi; Gaia Gatti; Patrick Maisonneuve; Barbara Valeri; Ugo Pastorino; Giuseppe Pelosi
Journal:  Virchows Arch       Date:  2017-01-04       Impact factor: 4.064

Review 2.  Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.

Authors:  Giuseppe Pelosi; Mauro Papotti; Guido Rindi; Aldo Scarpa
Journal:  Endocr Pathol       Date:  2014-06       Impact factor: 3.943

3.  Morphologic analysis of pulmonary neuroendocrine tumors.

Authors:  Seung Seok Lee; Myunghee Kang; Seung Yeon Ha; Jungsuk An; Mee Sook Roh; Chang Won Ha; Jungho Han
Journal:  Korean J Pathol       Date:  2013-02-25

Review 4.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

Review 5.  Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis.

Authors:  Marina K Baine; Natasha Rekhtman
Journal:  Transl Lung Cancer Res       Date:  2020-06

Review 6.  Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?

Authors:  Dmitriy Sonkin; Anish Thomas; Beverly A Teicher
Journal:  Lung Cancer Manag       Date:  2019-08-21

7.  Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors.

Authors:  Juxuan Zhang; Jiaxing Deng; Xiao Feng; Yilong Tan; Xin Li; Yixin Liu; Mengyue Li; Haitao Qi; Lefan Tang; Qingwei Meng; Haidan Yan; Lishuang Qi
Journal:  Front Genet       Date:  2022-08-29       Impact factor: 4.772

8.  Genomic Feature of a Rare Case of Mix Small-Cell and Large-Cell Neuroendocrine Lung Carcinoma: A Case Report.

Authors:  Youcai Zhu; Feng Zhang; Dong Yu; Fang Wang; Manxiang Yin; Liangye Chen; Chun Xiao; Yueyan Huang; Feng Ding
Journal:  Front Oncol       Date:  2022-01-18       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.